Randomized controlled trials ([@CIT0014], [@CIT0001], [@CIT0011]) and clinical series ([@CIT0013]) have shown a significant reduction in length of stay in hospital following lower limb arthroplasty with the implementation of enhanced recovery (ER) programs. ER programs are based on the use of multimodal strategies to improve analgesia while at the same time reducing the surgical stress response and organ dysfunction (including nausea, vomiting, and ileus), thus facilitating earlier patient mobilization and return to oral fluids and diet ([@CIT0009]). This enables commencement of functional rehabilitation within the first few hours after surgery ([@CIT0007], [@CIT0013]). The use of multimodal strategies has resulted in faster patient rehabilitation and improved satisfaction ([@CIT0008]).

Our hospital introduced an ER program for hip and knee arthroplasty in May 2008. We have previously published our findings of statistically significant reductions in length of hospital stay and mortality within 30 days and 90 days of surgery by the use of an ER program compared to our traditional protocol ([@CIT0012]). The 90-day mortality of 0.2% in our unit after implementation of an ER program is similar to that previously reported in units with established ER programs ([@CIT0006]).

Very few results have been published regarding comparison of longer-term mortality after implementation of ER programs in comparison to controls from a cohort of patients whereby multimodal strategies were not used in the perioperative period. A recent study from the United Kingdom found no difference in mortality 1 year after primary total knee arthroplasty following implementation of an ER program in comparison with a historical cohort ([@CIT0013]).

We now report on mortality more than 3 years postoperatively following the introduction of an ER program, in comparison to the results of our traditional protocol.

Patients and methods {#ss1}
====================

Data from 4,500 unselected consecutive primary hip and knee replacements were analyzed. 3,000 procedures were performed between March 2, 2004 and May 1, 2008, immediately prior to implementation of the enhanced recovery program (the traditional (TRAD) group); 1,500 procedures were performed with an enhanced recovery program (the enhanced recovery (ER) group) between May 2, 2008 and November 3, 2009. The treating surgeons' indications for hip and knee arthroplasty remained unchanged. The protocols that were followed in both groups have been published previously ([@CIT0012]).

The patients were from a consecutive unselected series. Comparison of patient demographics before surgery in the 2 groups---as previously published ([@CIT0012])---are presented in [Table 1](#T1){ref-type="table"}. Chi-squared test was used to compare proportions ([@CIT0005]).

###### 

Comparison of patient demographics preoperatively in the 2 groups

  ------------------------------------------------------------------------------------------------
                            TRAD\         ER\           p-value **[^a^](#T1-F1){ref-type="fn"}**
                            (n = 3,000)   (n = 1,500)   
  ------------------------- ------------- ------------- ------------------------------------------
  Mean age, years           69            68            

  THR                       1368          630           

  TKR                       1632          870           

  Sex (M : F)               1482 : 1518   711 : 789     0.2

  Co-morbidities, n (%)                                 

   Hypertension             921 (31)      673 (45)      \< 0.001

   Atrial fibrillation      143 (5)       84 (6)        0.3

   Ischemic heart disease   211 (7)       113 (8)       0.6

   Diabetes mellitus                                    

   insulin-dependent        20 (0.7)      18 (1)        0.09

   non-insulin-dependent    205 (7)       150 (10)      \< 0.001

   Chronic obstructive                                  

   pulmonary disease        85 (3)        67 (4)        0.006

   Alzheimer's disease      6 (0.2)       5 (0.3)       0.6
  ------------------------------------------------------------------------------------------------

**^a^**Chi-squared test with continuity correction.

Mortality data were obtained from the Office of National Statistics (ONS). In England, deaths must be registered within 5 days. Burials and cremations cannot be conducted without this registration documentation. These deaths are recorded by the ONS and are added to the patient's health service record. The cause of death for patients that died within our NHS trust was obtained from inspection of hospital case notes, and was cross-referenced with ONS data.

Statistics {#ss2}
----------

The death rates and cause-of-death data presented for postoperative times up to 2 years include the actual data for all 4,500 patients. There was a greater proportion of patients in the TRAD group with longer follow-up data. The death rates beyond 2 years are therefore only reported using Kaplan-Meier (K-M) survival analysis. K-M survival curves with Greenwood's 95% confidence interval (CI) were used to assess and compare the survival probability between groups (TRAD and ER). The log-rank test was used to test for any statistically significant difference between the 2 K-M curves ([@CIT0003]). Furthermore, the log-rank test was used to determine whether there were any differences in survival, between hip and knee arthroplasty, within each group.

Results {#ss3}
=======

After initiation of the ER program, the mortality rate following primary hip and knee arthroplasty was reduced (p = 0.05) at 2 years ([Table 2](#T2){ref-type="table"}). With time (up to 3.7 years), the difference in mortality appeared to increase as the K-M survival curves diverged (χ^2^log-rank = 16, p \< 0.001) ([Figure 1](#F1){ref-type="fig"}).

###### 

Comparison of mortality rates in the two groups

  ------------------------------------------------------------------
                    TRAD\         ER\           p-value\
                    (n = 3,000)   (n = 1,500)   (chi-squared test)
  ----------------- ------------- ------------- --------------------
  Dead by 1 year    63 (2.1%)     19 (1.3%)     0.05

  Dead by 2 years   114 (3.8%)    40 (2.7%)     0.05
  ------------------------------------------------------------------

![Kaplan-Meier (K-M) survival curves for both groups ± 95% Greenwood confidence interval (dotted lines). Note that the two K-M survival curves fall outwith the ± 95% Greenwood confidence intervals. The level of significance is 0.05.](ORT-84-40-g001){#F1}

In the ER group, with a sample size that was half that of the TRAD group, it could be expected that the number of deaths at different intervals postoperatively would be half that of the TRAD group. With time, the difference in mortality appeared to increase; there were 12 fewer deaths than expected in the ER group at 1 year and this increased to 17 fewer deaths at 2 years in the ER cohort of 1,500 patients. Although fewer patients in the ER group had 3.7-year follow-up, the projected difference at that point was 5% (75 patients).

From case notes and ONS data, we were unable to ascertain the cause of death of 9 patients in the TRAD group and of 7 patients in the ER group.

The cause of death data ([Figure 2](#F2){ref-type="fig"}) show that at 2 years after surgery, a greater proportion of deaths were related to malignant disease in the TRAD group than in the ER group. Almost half of the patients who died due to malignant disease within 2 years in the ER group (4 of 9) had a known diagnosis of cancer prior to arthroplasty surgery. In the TRAD group, approximately one third of deaths from malignant disease (14 of 36) were in patients who were known to have developed cancer before joint replacement surgery. When K-M survival probability graphs were plotted for both groups after exclusion of all deaths that had been due to malignant disease, there were divergent curves (χ^2^log-rank = 11, p \< 0.001), indicating that a survival benefit remained up to 3.7 years after surgery for patients who underwent an ER protocol.

![Cause of death for patients who died up to 2 years post surgery, reported as a rate per 1,000 procedures.](ORT-84-40-g002){#F2}

Discussion {#ss4}
==========

The ER program is intended to facilitate an early return to function by minimizing stress-induced organ dysfunction after major surgery and its associated morbidity ([@CIT0008]).

Implementation of the ER program appeared to have a positive effect on reducing patient mortality following lower limb arthroplasty; this persisted up to 3.7 years postoperatively. The reason for this prolonged and apparently increasing beneficial effect is not known, but it may relate to the reduced stress response, shorter hospital stay, and improved pain control in the ER program group ([@CIT0008], [@CIT0013]). With the initiation of an ER program in our unit, there was a statistically significant decrease in the postoperative transfusion rate. In contrast, in the TRAD group, there tended to be a greater range of complications---which included return to theater, hospital re-admission, stroke, myocardial infarction, acute renal failure, and thromboembolic events---within the first 2 postoperative months ([@CIT0012]). A recent review of prospectively collected multicenter data from over 100,000 patients who had undergone surgical procedures (a proportion of whom had THRs) showed that the occurrence of a postoperative complication within the first 30 days reduced median patient survival at 5 years, independently of patient risk preoperatively ([@CIT0010]). The authors suggested that the presence of an inflammatory response related to the postoperative complication may have been a contributory factor to the reduced longer-term survival. Likewise, the reduced 30-day postoperative complication incidence in the ER group in our study may explain the improved longer-term survival. In addition, the stated aim of ER programs---to use multimodal strategies to reduce the surgery-mediated inflammatory stress response ([@CIT0009])---may in itself contribute to improved longer-term survival.

There has been an increase in detection rates, possibly related to better patient awareness, and there have also been improvements in treatment modalities for the most common malignant diseases in the United Kingdom, namely prostate cancer, breast cancer, colorectal cancer, and lung cancer. The benefits gained from these are evident from the steady increase in 1-year survival rates after diagnosis of a malignant disease over the last 5 years ([@CIT0004]). This may partly explain the higher proportion of deaths related to malignant disease in the TRAD group, which was the historical cohort. Furthermore, there is some evidence in the literature to suggest an increase in recurrence of malignant disease after blood transfusion ([@CIT0002]). The rates of malignant disease before surgery in the ER and TRAD groups were similar, but mortality due to malignant disease within 2 years post surgery was greater in the TRAD group. As the ER group had a lower postoperative transfusion rate ([@CIT0012]), this may have been a factor in the observed rate of deaths due to malignancy in our study.

The proportion of deaths related to the more commonly encountered post-surgical complications such as stroke, myocardial infarction, cardiac failure, pneumonia, respiratory failure, pulmonary embolism, and renal failure was greater in the TRAD group.

This is the first observational study to specifically assess medium-term mortality in a large number of patients before and after the implementation of an ER program for hip and knee arthroplasty. We found a survival benefit in the longer term following implementation of the ER program. The cause of this survival benefit is still not known, but the present study further supports the routine use of ER programs for hip and knee replacement.
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